Decipher Labs P/B Ratio
Decipher Labs (DECIPHER) P/B ratio is 0.31 (Low), book value per share ₹23.00 vs Healthcare average P/B of -0.29 — Very Low - Significant discount to book value, potential distress or value opportunity. View DECIPHER 52-week performance for the annual high/low range and current price position.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
DECIPHER P/B Ratio — Valuation Insights & Book Value Analysis
Decipher Labs price-to-book ratio interpretation, valuation status and historical context — current P/B 0.31 (Low). For live price, earnings yield and the full fundamental profile, see Decipher Labs share price chart.
- Stock appears undervalued with PB of 0.31, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 88.2% below historical average
- Trading at premium to sector average PB of -0.29
Decipher Labs P/B Ratio Historical Trend
DECIPHER annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Review Decipher Labs price earnings to evaluate earnings-based valuation against sector peers.
DECIPHER Historical P/B Ratio — Book Value Per Share & Year-End Price
Decipher Labs annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.45 | ₹23.0 | ₹10.45 | ₹23 | Low |
| 2024 | 0.68 | ₹22.0 | ₹14.95 | ₹22 | Low |
| 2023 | 0.76 | ₹23.0 | ₹17.43 | ₹23 | Low |
| 2022 | 1.31 | ₹24.0 | ₹31.55 | ₹24 | Moderate |
| 2021 | 9.98 | ₹14.0 | ₹139.70 | ₹14 | High |
DECIPHER vs Healthcare Peers — P/B Ratio Comparison
Decipher Labs P/B 0.31 vs Healthcare average -0.29, median 0.58 — range -14.47–1.12.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -14.47 | ₹18 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Parmax Pharma | PARMAX | -5.61 | ₹39 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.22 | ₹72 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹115 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.5 | ₹44 | Low |